- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 2 residues within 4Å:- Chain A: D.137
- Ligands: ZN.1
6 PLIP interactions:1 interactions with chain A, 5 Ligand-Water interactions- Metal complexes: A:D.137, H2O.1, H2O.2, H2O.3, H2O.4, H2O.8
MG.12: 2 residues within 4Å:- Chain B: D.137
- Ligands: ZN.11
6 PLIP interactions:1 interactions with chain B, 5 Ligand-Water interactions- Metal complexes: B:D.137, H2O.12, H2O.12, H2O.13, H2O.14, H2O.16
- 2 x AJX: (1S)-1-[3-(1H-indol-3-yl)propyl]-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-carbaldehyde(Non-covalent)
AJX.3: 13 residues within 4Å:- Chain A: Y.95, H.96, M.209, H.212, N.257, W.268, T.269, I.272, F.276, M.293, Q.305, F.308, I.312
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:Y.95, A:H.212, A:I.272, A:I.272, A:F.308, A:I.312, A:I.312
- Hydrogen bonds: A:Q.305
- Water bridges: A:T.207, A:M.209
AJX.13: 13 residues within 4Å:- Chain B: Y.95, H.96, M.209, H.212, N.257, W.268, T.269, I.272, F.276, M.293, Q.305, F.308, I.312
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:Y.95, B:H.212, B:I.272, B:I.272, B:F.308, B:F.308, B:I.312, B:I.312, B:I.312
- Hydrogen bonds: B:Q.305
- Water bridges: B:M.209
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 6 residues within 4Å:- Chain A: S.144, F.276, Q.279, S.291, P.292, C.294
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.144, A:S.144, A:P.292
- Water bridges: A:Q.279
EDO.5: 4 residues within 4Å:- Chain A: K.198, I.201, D.202
- Chain B: N.160
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Water bridges: B:D.161, A:D.202
- Hydrogen bonds: A:D.202
EDO.6: 6 residues within 4Å:- Chain A: T.70, F.71, K.72, N.187, L.188, Q.192
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.192, A:Q.192
EDO.7: 8 residues within 4Å:- Chain A: M.222, T.225, K.226, K.227, L.234, L.235, L.236, D.241
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:T.225, A:K.227, A:L.235
- Water bridges: A:T.225, A:N.238
EDO.8: 4 residues within 4Å:- Chain A: R.266, E.302, W.341, Y.342
2 PLIP interactions:2 interactions with chain A- Water bridges: A:R.266, A:Y.342
EDO.9: 3 residues within 4Å:- Chain A: D.337, N.338, W.341
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.338
EDO.10: 5 residues within 4Å:- Chain A: N.51, A.91, N.97, N.98, I.99
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.51, A:A.91, A:N.98
- Water bridges: A:N.98
EDO.14: 5 residues within 4Å:- Chain B: S.144, F.276, S.291, P.292, C.294
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.144, B:S.144, B:P.292
- Water bridges: B:S.291
EDO.15: 6 residues within 4Å:- Chain B: N.51, A.91, N.97, N.98, I.99
- Ligands: EDO.16
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.51, B:N.98
- Water bridges: B:N.98
EDO.16: 7 residues within 4Å:- Chain B: N.51, E.86, D.87, Y.89, A.91, N.98
- Ligands: EDO.15
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:D.87, B:A.91, B:N.98
- Water bridges: B:D.87, B:N.98
EDO.17: 4 residues within 4Å:- Chain B: R.266, E.302, W.341, Y.342
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.266, B:E.302
- Water bridges: B:Y.342
EDO.18: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)EDO.19: 5 residues within 4Å:- Chain B: L.235, L.236, D.237, N.238, D.241
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:L.235, B:D.237, B:N.238, B:D.241
EDO.20: 4 residues within 4Å:- Chain A: N.160
- Chain B: K.198, I.201, D.202
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.202
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Structure-Aided Identification and Optimization of Tetrahydro-isoquinolines as Novel PDE4 Inhibitors Leading to Discovery of an Effective Antipsoriasis Agent. J.Med.Chem. (2019)
- Release Date
- 2019-10-23
- Peptides
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x AJX: (1S)-1-[3-(1H-indol-3-yl)propyl]-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-carbaldehyde(Non-covalent)
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Structure-Aided Identification and Optimization of Tetrahydro-isoquinolines as Novel PDE4 Inhibitors Leading to Discovery of an Effective Antipsoriasis Agent. J.Med.Chem. (2019)
- Release Date
- 2019-10-23
- Peptides
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B